Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Effects of semaglutide on patient-reported outcomes in individuals with peripheral artery disease and type 2 diabetes: Findings from the STRIDE trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Diabetes
Congress short oral presentation
GLP-1 RA
Semaglutide
Clinical